Post-workout benefits of PeakATP sports nutrition validated in clinical study
23 Aug 2023 --- A new clinical study by researchers from the University of Central Florida has demonstrated improved mental clarity, focus and reaction times post-exercise of US-based pharma company TSI’s sports nutrition and nootropic ingredient PeakATP. The findings have been published in Frontiers in Nutrition.
The data suggests the supplement could mitigate exercise-induced cognitive dysfunction following high-intensity exercise. Preventing cognitive dysfunction after exercise is valuable to athletes.
The study supports the product’s applications for post-workout benefits, where these details were previously only substantiated through feedback and observations by athletes.
“We’ve always understood how PeakATP works as a pre-workout supplement. But we’ve also heard from athletes and previous study participants that they feel better and have less brain fog post-exercise with this ingredient,” says Larry Kolb, group president at TSI. “That’s why this study came to life. We wanted to see if there was something measurable going on.”
Energy for exercise
PeakATP is a patented form of Adenosine 5’-Triphosphate (ATP) Disodium, identical to the structure of ATP produced in the body. The supplement boosts energy in combination with exercise, allowing sporters to achieve more and experience less fatigue.
“Professional athletes understand the importance of not having their reaction time decline at crucial times,” explains Kolb. “Improved cognitive benefits and reaction times, after participating in a high-intensity activity for a while, are good for team athletes as well as golfers, tennis players and anyone else who needs to maintain their focus throughout a match or game.”
PeakATP significantly reduces fatigue in elite athletics.
For example, high-intensity sprint exercises can cause lapses in concentration, decision-making and skill performance.
Experimenting with response times
The researchers conducted a placebo-controlled crossover study with 20 men and women in their 20s involving proactive and reactive response time testing.
Participants of the control study received 400 mg of PeakATP for 14 days, followed by more testing. Thirty minutes after taking the supplement, they completed another series of response-time tests and the cognitive questionnaire.
They then did an exercise warm-up and three minutes of high-intensity cycling. After a 14-day washout period, participants repeated the process with the alternative supplement.
“Compared with the placebo, PeakATP prevented the decline in proactive reaction times immediately post-exercise and at 60 minutes post-exercise. Supplementation decreased the number of errors made during a reactive visuomotor task before and after high-intensity exercise,” notes Dr. John Rathmacher, group director, clinical research at TSI.
“This is significant for more than professional or elite athletes. For example, these post-exercise benefits also add value to anyone who works out early in the morning and doesn’t want to arrive at the office suffering from brain fog.”
Meanwhile, using TSI’s 2-hydroxybenzylamine (2-HOBA) acetate offering, Hobamine significantly increases biomarkers for immunity and inflammation. According to the National Institutes of Health, supplementation with 2-HOBA could reduce inflammation in younger and older adults.
By Inga de Jong
